Tools: Use the updated AnticoagEvaluator to make informed decisions on initiation of antithrombotic therapy for patients with atrial fibrillation (AF) who do not have moderate to severe mitral stenosis or a mechanical heart valve. App updates include expanded advice from the 2019 Focused Update to the 2014 ACC/AHA/HRS Guideline for the Management of Patients with AF.
Submit Feedback
Publish Date or Last Revised
January 8, 2024
Resource Type
- Shared Decision-Making
- Tools
Therapeutic Area
Atrial Fibrillation
Management
Anticoagulation and Stroke Prevention